Follow
Julia G Prado
Julia G Prado
Irsicaixa
Verified email at irsicaixa.es
Title
Cited by
Cited by
Year
CD8+ T-cell responses to different HIV proteins have discordant associations with viral load
P Kiepiela, K Ngumbela, C Thobakgale, D Ramduth, I Honeyborne, ...
Nature medicine 13 (1), 46-53, 2007
12232007
HIV evolution: CTL escape mutation and reversion after transmission
AJ Leslie, KJ Pfafferott, P Chetty, R Draenert, MM Addo, M Feeney, ...
Nature medicine 10 (3), 282-289, 2004
10572004
Adaptation of HIV-1 to human leukocyte antigen class I
Y Kawashima, K Pfafferott, J Frater, P Matthews, R Payne, M Addo, ...
Nature 458 (7238), 641-645, 2009
5562009
Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1
J Martinez-Picado, JG Prado, EE Fry, K Pfafferott, A Leslie, S Chetty, ...
Journal of virology 80 (7), 3617-3623, 2006
5452006
Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection
R Draenert, S Le Gall, KJ Pfafferott, AJ Leslie, P Chetty, C Brander, ...
The Journal of experimental medicine 199 (7), 905-915, 2004
3842004
Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B* 5703-restricted Gag epitope in chronic human …
H Crawford, JG Prado, A Leslie, S Hué, I Honeyborne, S Reddy, ...
Journal of virology 81 (15), 8346-8351, 2007
2662007
HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells
A Prendergast, JG Prado, YH Kang, F Chen, LA Riddell, G Luzzi, ...
Aids 24 (4), 491-502, 2010
2322010
Evolution of HLA-B* 5703 HIV-1 escape mutations in HLA-B* 5703–positive individuals and their transmission recipients
H Crawford, W Lumm, A Leslie, M Schaefer, D Boeras, JG Prado, J Tang, ...
Journal of Experimental Medicine 206 (4), 909-921, 2009
2072009
Restriction factors: from intrinsic viral restriction to shaping cellular immunity against HIV-1
M Colomer-Lluch, A Ruiz, A Moris, JG Prado
Frontiers in immunology 9, 429836, 2018
1642018
Selection of drug-resistant HIV-1 mutants in response to repeated structured treatment interruptions
J Martinez-Picado, K Morales-Lopetegi, T Wrin, JG Prado, SDW Frost, ...
Aids 16 (6), 895-899, 2002
1422002
Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity
JG Prado, T Wrin, J Beauchaine, L Ruiz, CJ Petropoulos, SDW Frost, ...
Aids 16 (7), 1009-1017, 2002
1402002
Sialyllactose in viral membrane gangliosides is a novel molecular recognition pattern for mature dendritic cell capture of HIV-1
N Izquierdo-Useros, M Lorizate, FX Contreras, MT Rodriguez-Plata, ...
PLoS biology 10 (4), e1001315, 2012
1082012
Efficacious Early Antiviral Activity of HIV Gag- and Pol-Specific HLA-B*2705-Restricted CD8+ T Cells
RP Payne, H Kløverpris, JB Sacha, Z Brumme, C Brumme, S Buus, ...
Journal of virology 84 (20), 10543-10557, 2010
1082010
Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study
L Ruiz, E Ribera, A Bonjoch, J Romeu, J Martinez-Picado, R Paredes, ...
The Journal of infectious diseases 188 (7), 977-985, 2003
1042003
Resident memory T cells are a cellular reservoir for HIV in the cervical mucosa
J Cantero-Pérez, J Grau-Expósito, C Serra-Peinado, DA Rosero, ...
Nature communications 10 (1), 4739, 2019
992019
Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia
D Sánchez-Martínez, ML Baroni, F Gutierrez-Agüera, H Roca-Ho, ...
Blood, The Journal of the American Society of Hematology 133 (21), 2291-2304, 2019
962019
Assessment of the feasibility and safety of durvalumab for treatment of solid tumors in patients with HIV-1 infection: the phase 2 DURVAST study
M Gonzalez-Cao, T Morán, J Dalmau, J Garcia-Corbacho, JWP Bracht, ...
JAMA oncology 6 (7), 1063-1067, 2020
792020
CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir
R Badia, E Ballana, M Castellví, E García-Vidal, M Pujantell, B Clotet, ...
Nature communications 9 (1), 2739, 2018
742018
Factors leading to the loss of natural elite control of HIV-1 infection
M Pernas, L Tarancon-Diez, E Rodriguez-Gallego, J Gomez, JG Prado, ...
Journal of virology 92 (5), 10.1128/jvi. 01805-17, 2018
742018
Long-term spontaneous control of HIV-1 is related to low frequency of infected cells and inefficient viral reactivation
N Noel, R Peña, A David, V Avettand-Fenoel, I Erkizia, E Jimenez, ...
Journal of virology 90 (13), 6148-6158, 2016
622016
The system can't perform the operation now. Try again later.
Articles 1–20